Index by author

May 01, 1998; Volume 65, Issue 5

    Matthew T. Roe

  • The EPILOG Trial

    Matthew T. Roe, MD and David J. Moliterno, MD
    • Cleveland Clinic Journal of Medicine May 1998, 65 (5) 267-272;
    • The platelet glycoprotein Ilb/IIIa inhibitor abciximab, together with heparin in a low, weight-adjusted dose, markedly reduced the risk of acute ischemic complications during angioplasty, without increasing the risk of hemorrhage.

  • Maurie Markman

  • Cancer information and the Internet: Benefits and risks

    Maurie Markman, MD
    • Cleveland Clinic Journal of Medicine May 1998, 65 (5) 274-276;
    • The Internet has potential to educate the public about health care, Kit also can harm through misleading and deceptive information.